Shahram Salek-Ardakani
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Shahram Salek-Ardakani
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shahram Salek-Ardakani
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Graduate Degree Corporate Officer/Principal | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Bavarian Nordic, Inc.
 Bavarian Nordic, Inc. Miscellaneous Commercial ServicesCommercial Services Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
| KITE PHARMA INC | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| IGM BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
ATP Capital LP
 ATP Capital LP Real Estate DevelopmentFinance ATP Capital LP provides real estate investment and management services. The company was founded by Jonathan R. Malkin in 1997 and is headquartered in Clearwater Beach, FL. | Real Estate Development | Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin | |
| EFFECTOR THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| UCLA Anderson School of Management | College/University | Masters Business Admin | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO | |
Lipidio Pharmaceuticals, Inc.
 Lipidio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lipidio Pharmaceuticals, Inc. develops and manufactures medicines. It focuses on developing drugs to treat diseases associated with excess body fat and its lead program, GDD3898, is being investigated for the treatment of nonalcoholic steatohepatitis (NASH) and Prader Willi syndrome (PWS), an orphan disease, and anti-psychotic drug induced weight gain (AIWG). The company was founded by Jay Edward Birnbaum and is headquartered San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| University of San Francisco | College/University | Undergraduate Degree | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| MIRAVANT MEDICAL TECHNOLOGIES INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY. | Medical/Nursing Services | Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Santa Barbara & Ventura Colleges of Law | College/University | Graduate Degree | |
| University of New England | College/University | Doctorate Degree | |
Otto Eckart GmbH
 Otto Eckart GmbH Other Consumer ServicesConsumer Services Otto Eckart GmbH operates museums. The private company is based in Munich, Germany. The German company was founded in 1996 by Otto Eckart. The CEO is Martin Schütze. | Other Consumer Services | Director/Board Member | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree | |
Aitia, Inc.
 Aitia, Inc. Miscellaneous Commercial ServicesCommercial Services GNS Healthcare, Inc. provides analytics solutions for the healthcare industry. The firm offers solutions for electronic health records, claims, clinical and incentive programs, reward, product development solutions for biopharmaceutical, diagnostic, consumer product, and medical device companies and publications, conference abstracts, and presentations. The company was founded by Colin Hill and Iya Khalil in 2000 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Institute For Stem Cell Biology & Regenerative Medicine | Corporate Officer/Principal | ||
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member | |
Nerio Therapeutics, Inc.
 Nerio Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nerio Therapeutics, Inc. provides biotechnology services. The company is headquartered in La Jolla, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Alliance Management Group | Founder | ||
| ARRIVENT BIOPHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| CITIGROUP INC. | Major Banks | Corporate Officer/Principal | |
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
| RESPONSE BIOMEDICAL CORP | Miscellaneous Commercial Services | Chairman | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 45 |
| Deutschland | 4 |
| Kanada | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 15 |
| Commercial Services | 8 |
| Finance | 5 |
| Health Services | 3 |
Operativ
| Director/Board Member | 40 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 18 |
| Founder | 10 |
| Director of Finance/CFO | 8 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Alana McNulty | 13 |
| Winston Kung | 13 |
| Ronald Barrett | 9 |
| Wayne Godfrey | 9 |
| Stefan Heller | 9 |
| Byron Robinson | 7 |
| Brenda Van Vreeswyk | 4 |
- Börse
- Insiders
- Shahram Salek-Ardakani
- Unternehmensverbindungen
